These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10091145)

  • 21. Distribution of hepatitis C virus genotypes in beta-thalassaemic patients from Northern India.
    Chakravarti A; Verma V
    Transfus Med; 2006 Dec; 16(6):433-8. PubMed ID: 17163874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary hypertension in thalassaemia major patients with normal left ventricular systolic function.
    Hagar RW; Morris CR; Vichinsky EP
    Br J Haematol; 2006 May; 133(4):433-5. PubMed ID: 16643452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of diabetes mellitus and impaired glucose tolerance in beta-thalassemia patients with and without hepatitis C virus infection.
    Mowla A; Karimi M; Afrasiabi A; De Sanctis V
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():282-4. PubMed ID: 16462712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baseline levels of plasma endothelin-1 (ET-1) and changes during transfusion in thalassemic patients.
    Viprakasit V; Kankirawatana S; Akarasereenont P; Durongpisitkul K; Chotewuttakorn S; Tanphaichitr VS
    Am J Hematol; 2002 Jul; 70(3):260-2. PubMed ID: 12118430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac disease in beta-thalassaemia major: Is it reversible?
    Atiq M; Bana M; Ahmed US; Bano S; Yousuf M; Fadoo Z; Khurshid M
    Singapore Med J; 2006 Aug; 47(8):693-6. PubMed ID: 16865210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of bone mineral density and bone metabolism in children with multiple bone fractures.
    Michałus I; Chlebna-Sokół D; Rusińska A; Jakubowska-Pietkiewicz E; Kulińska-Szukalska K
    Ortop Traumatol Rehabil; 2008; 10(6):602-12. PubMed ID: 19153549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology and chelation therapy effects on glucose homeostasis in thalassaemic patients.
    Gamberini MR; Fortini M; Gilli G; Testa MR; De Sanctis V
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():867-9. PubMed ID: 10091159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antioxidant micronutrients in children with thalassaemia in Egypt.
    Nasr MR; Ali S; Shaker M; Elgabry E
    East Mediterr Health J; 2002; 8(4-5):490-5. PubMed ID: 15603029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma chitotriosidase activity in patients with beta-thalassemia.
    Altarescu G; Rudensky B; Abrahamov A; Goldfarb A; Rund D; Zimran A; Elstein D
    Am J Hematol; 2002 Sep; 71(1):7-10. PubMed ID: 12221666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The validity of pallor as a clinical sign of anemia in cases with beta-thalassemia.
    Yalçin SS; Unal S; Gümrük F; Yurdakök K
    Turk J Pediatr; 2007; 49(4):408-12. PubMed ID: 18246743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endocrinopathies in patients with transfusion-dependent beta-thalassemia.
    Mehrvar A; Azarkeivan A; Faranoush M; Mehrvar N; Saberinedjad J; Ghorbani R; Vossough P
    Pediatr Hematol Oncol; 2008; 25(3):187-94. PubMed ID: 18432501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth in children after bone marrow transplantation for thalassemia.
    Gaziev J; Galimberti M; Giardini C; Baronciani D; Lucarelli G
    Bone Marrow Transplant; 1993; 12 Suppl 1():100-1. PubMed ID: 8374543
    [No Abstract]   [Full Text] [Related]  

  • 33. Early iron reduction programme for thalassaemia patients after bone marrow transplantation.
    Li CK; Lai DH; Shing MM; Chik KW; Lee V; Yuen PM
    Bone Marrow Transplant; 2000 Mar; 25(6):653-6. PubMed ID: 10734300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short stature and body proportion in thalassaemia.
    Caruso-Nicoletti M; De Sanctis V; Capra M; Cardinale G; Cuccia L; Di Gregorio F; Filosa A; Galati MC; Lauriola A; Malizia R; Mangiagli A; Massolo F; Mastrangelo C; Meo A; Messina MF; Ponzi G; Raiola G; Ruggiero L; Tamborino G; Saviano A
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():811-6. PubMed ID: 10091151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of endocrine complications in beta-thalassaemia major in the Islamic Republic of Iran.
    Karamifar H; Shahriari M; Sadjadian N
    East Mediterr Health J; 2003; 9(1-2):55-60. PubMed ID: 15562733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced relative risk of fractures among users of lithium.
    Vestergaard P; Rejnmark L; Mosekilde L
    Calcif Tissue Int; 2005 Jul; 77(1):1-8. PubMed ID: 16007481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal study of survival and causes of death in patients with thalassemia major in Greece.
    Ladis V; Chouliaras G; Berdousi H; Kanavakis E; Kattamis C
    Ann N Y Acad Sci; 2005; 1054():445-50. PubMed ID: 16339695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and outcome of paediatric and adolescent limb fractures in rural Zambia.
    Krabbe CA; Rutten JP; Phiri Y; Heiji HA
    S Afr J Surg; 2003 Nov; 41(4):89-91. PubMed ID: 14768143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fracture patterns in children and young adults who fall from significant heights.
    Sawyer JR; Flynn JM; Dormans JP; Catalano J; Drummond DS
    J Pediatr Orthop; 2000; 20(2):197-202. PubMed ID: 10739282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemostatic disorders in nonsplenectomized and splenectomized thalassaemic children.
    Shebl SS; el-Sharkawy HM; el-Fadaly NH
    East Mediterr Health J; 1999 Nov; 5(6):1171-7. PubMed ID: 11924107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.